Pharmaceuticals
Healthcare
Piramal to buy five products from Janssen Pharmaceutica for up to $175 mn
Ajay Piramal-led Piramal Enterprises Ltd has sealed a deal to buy a clutch of products from Janssen Pharmaceutica NV for ......
Healthcare
Cipla eyes fresh push into China
Indian pharmaceuticals giant Cipla Ltd that has scaled down its business in China over the last three-four years even as ......
Healthcare
Temasek-backed Intas to buy Teva's operations under Actavis in UK & Ireland for $769 mn
World’s largest generic drugmaker Teva Pharmaceutical Industries Ltd said on Wednesday it has agreed to sell assets and operations of ......
Healthcare
Bharat Serums & Vaccines raises fresh PE money
Bharat Serums & Vaccines Ltd. has raised additional capital as part of a larger transaction where the promoters sold some ......
Healthcare
Jacob Ballas makes modest returns from Vivimed Labs' part-exit
Mid-market private equity firm Jacob Ballas Capital has marked its third liquidity event this year as it looks to harvest ......
Healthcare
Vitalic Health, Athena Life tie up to launch nutraceutical products
Chennai-based Vitalic Health Pvt. Ltd said on Wednesday it has stitched a deal with Athena Life Sciences Pvt. Ltd to ......
Healthcare
Cipla BioTec hires banker for biggest PE fundraise in biosimilar space
Cipla BioTec Pvt Ltd, the bio-similar firm incubated by pharmaceuticals giant Cipla Ltd to develop anti-cancer drugs, has initiated the ......
Healthcare
Morepen in talks to sell OTC business
Morepen Laboratories is in advanced discussions to sell its over the counter (OTC) business to Piramal Enterprises. The firm has hired ......
Healthcare
Stemade Biotech moves court against drugmaker Generic Partners
Stemade Biotech Pvt. Ltd, a boutique business advisory firm, has dragged Australian pharmaceutical company Generic Partners Pty Ltd to court ......
Healthcare
Actis elicits interest from investors for stake in Symbiotec Pharmalab
Private equity firm Actis Capital, which invested in Symbiotec Pharmalab in October 2013, has received interest from investors for its ......